Citations

Clear

2511 citation(s) found for "Yang, Yu".

Hypercholesterolemia Impairs Nonstenotic Kidney Outcomes After Reversal of Experimental Renovascular Hypertension
Eirin, Alfonso , Zhu, Xiang-Yang, Textor, Stephen C., Lerman, Lilach O. , Sun, Dong , Chen, Zhi , Sun, Dong , Chen, Zhi , Lerman, Amir , Eirin, Alfonso

Mayo Clinic

American Journal of Hypertension | January 7, 2016 | Volume: 29 | Issue: 7 | Pages: 853-859

10.1093/ajh/hpv222 | PMID 26739189 Get It

Abstract BACKGROUND Revascularization of a stenotic renal artery improves kidney function only in select patients with renovascular hypertension (HT) secondary to atherosclerosis. However, the effects of reversal of renovascular HT (RRHT) on the nonstenotic kidney are unclear. We hypothesized that concurrent hypercholesterolemia (HC) attenuates nonstenotic kidney recovery. METHODS Female domestic pigs were randomized as Normal, renovascular HT, HT+RRHT, HTC (renovascular HT and HC), and HTC+RHT ( n = 7 each). RRHT or sham was performed after 6 weeks of HT. Nonstenotic renal blood flow, glomerular filtration rate, and injurious pathways were studied 4 weeks later. RESULTS Mean arterial pressure increased similarly in HT and HTC and decreased after RRHT. Oxidative stress increased in HT and HTC kidneys, and decreased in HT+RRHT, but remained elevated in HTC+RRHT. Renal interstitial fibrosis, glomerulosclerosis, and tubular injury were all attenuated in HT+RRHT, but not HTC+RRHT. Endothelin-1 signaling and PGF2α isoprostane levels were elevated in both HTC and HTC+RRHT pigs. CONCLUSIONS RRHT reverses nonstenotic kidney injury in experimental renovascular HT, but concurrent HC blunts regression of kidney injury, possibly due to predominant vasoconstrictors and oxidative stress. These findings reinforce the contribution of the nonstenotic kidney and of prevailing cardiovascular risk factors to irreversibility of kidney dysfunction after revascularization.
SCAI expert consensus statement: Evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologıa Interven
Iliescu, Cezar , Herrmann, Joerg , Yang, Eric H. , Charitakis, Konstantinos, Hakeem, Abdul , Tοutouzas, Konstantinos, Leesar, Massoud A. , Marmagkiolis, Konstantinos , Grines, Cindy L. , Çilingiroğlu, Mehmet , Yang, Eric

Mayo Clinic

Catheterization and Cardiovascular Interventions | December 23, 2015 | Volume: 87 | Issue: 5 | Pages: 895-899

10.1002/ccd.26375 | PMID 26700403 Get It

In the United States alone, there are currently approximately 14.5 million cancer survivors, and this number is expected to increase to 20 million by 2020. Cancer therapies can cause significant injury to the vasculature, resulting in angina, acute coronary syndromes (ACS), stroke, critical limb ischemia, arrhythmias, and heart failure, independently from the direct myocardial or pericardial damage from the malignancy itself. Consequently, the need for invasive evaluation and management in the cardiac catheterization laboratory (CCL) for such patients has been increasing. In recognition of the need for a document on special considerations for cancer patients in the CCL, the Society for Cardiovascular Angiography and Interventions (SCAI) commissioned a consensus group to provide recommendations based on the published medical literature and on the expertise of operators with accumulated experience in the cardiac catheterization of cancer patients. © 2015 Wiley Periodicals, Inc.
P2‐170: Plasma ceramides predict age‐related differences in white matter microstructure
Venkatraman, Vijay , An, Yang , Bandaru, Veera Venkata Ratnam, Resnick, Susan M. , Gonzalez, Christopher E. , Landman, Bennett A , Haughey, Norman J. , Ferrucci, Luigi , Mielke, Michelle M.

Mayo Clinic

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_12 | Pages: No page available

10.1016/j.jalz.2015.06.709 Get It

Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer
Wu, Changping , Jin, Xin , Yang, Yinhui , He, Yundong , Ding, Liya , Pan, Yunqian , Yang, H. J. , Chen, Shuai , Jiang, Jingting , Huang, Haojie , Jin, Xin

Mayo Clinic

Oncotarget | December 9, 2015 | Volume: 7 | Issue: 3 | Pages: 3440-3452

10.18632/oncotarget.6497 | PMID 26657505 Get It

Impact of access to NCI‐ and NCCN‐designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis
Advani, Pooja , Yang, Dongyun , Ghosh, Radhika , Swaika, Abhisek, Foran, James M. , Colón‐Otero, Gerardo , Chanan‐Khan, Asher , Chanan-Khan, Asher, Ailawadhi, Sikander , Roy, Vivek

Mayo Clinic

Cancer | November 13, 2015 | Volume: 122 | Issue: 4 | Pages: 618-625

10.1002/cncr.29771 | PMID 26565660 Get It

BACKGROUNDNational Cancer Institute (NCI)/National Comprehensive Cancer Network (NCCN)–designated cancer centers (CCs) offer patients state‐of‐the‐art treatment, but their impact on multiple myeloma (MM) patient outcomes has not been evaluated.METHODSAdult MM patients diagnosed between 1973 and 2011 were identified from the Surveillance, Epidemiology, and End Results database and were stratified by the county of residence at the time of diagnosis and the year of CC designation. The influence of NCI/NCCN CC access, race, and the year of diagnosis on overall survival (OS) was evaluated with a Cox regression model.RESULTSA statistically significant OS improvement was noted in patients diagnosed after 1995 with access to 2 or more NCI CCs overall (P = .002 for 1996‐2002; P < .001 for 2003‐2011) and by race for whites (hazard ratio [HR] for 1996‐2002, 0.85; 95% confidence interval [CI], 0.78‐0.91; HR for 2003‐2011, 0.85; 95% CI, 0.79‐0.91) but not for nonwhites. For NCCN access, improvement was seen in 1996‐2002 (P = .003), in 2003‐2011 (P < .001), and by race for whites (HR, 0.917; 95% CI, 0.88‐0.95) and nonwhites (0.94; 95% CI, 0.89‐0.99), but within nonwhites, this was true only for African Americans (AAs; HR, 0.88; 95% CI, 0.81‐0.97) and not for Asians, Hispanics, or Native Americans.CONCLUSIONSImprovement in OS was seen in MM patients diagnosed after 1995 with access to 1 NCCN CC or 2 or more NCI CCs. NCI access benefited only whites, whereas NCCN access benefited only white and AA patients. No OS benefit was seen for any subgroup with access to only 1 NCI center. Eliminating racial disparities in health care access and utilization is needed to improve outcomes. Cancer 2016;122:618–625. © 2015 American Cancer Society.
Secondhand Tobacco Smoke Exposure and Lung Adenocarcinoma In Situ /Minimally Invasive Adenocarcinoma (AIS/MIA)
Kim, Claire H., Lee, Yuan-Chin Amy, Hung, Rayjean J., Wampfler, Jason A. , Chang, Shen-Chih, Ugolini, Donatella, Neri, Monica , Schwartz, Ann G. , Morgenstern, Hal, Zhang, Zuo‐Feng , Hung, Rayjean J. , Xie, Dong , Hung, Rayjean J., Boffetta, Paolo , Coté, Michele L. , Marchand, Loı̈c Le , Christiani, David C. , Yang, Ping , Hung, Rayjean J

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | October 26, 2015 | Volume: 24 | Issue: 12 | Pages: 1902-1906

10.1158/1055-9965.epi-15-0436 | PMID 26503035 Get It

Abstract The aim of this study was to estimate the effect of exposure to secondhand tobacco smoke on the incidence of lung adenocarcinoma in situ/minimally invasive adenocarcinoma (AIS/MIA). Data from seven case–control studies participating in the International Lung Cancer Consortium (ILCCO) were pooled, resulting in 625 cases of AIS/MIA and 7,403 controls, of whom 170 cases and 3,035 controls were never smokers. Unconditional logistic regression was used to estimate adjusted ORs (ORadj) and 95% confidence intervals (CI), controlling for age, sex, race, smoking status (ever/never), and pack-years of smoking. Study center was included in the models as a random-effects intercept term. Ever versus never exposure to secondhand tobacco smoke was positively associated with AIS/MIA incidence in all subjects (ORadj = 1.48; 95% CI, 1.14–1.93) and in never smokers (ORadj = 1.45; 95% CI, 1.00–2.12). There was, however, appreciable heterogeneity of ORadj across studies (P = 0.01), and the pooled estimates were largely influenced by one large study (40% of all cases and 30% of all controls). These findings provide weak evidence for an effect of secondhand tobacco smoke exposure on AIS/MIA incidence. Further studies are needed to assess the impact of secondhand tobacco smoke exposure using the newly recommended classification of subtypes of lung adenocarcinoma. Cancer Epidemiol Biomarkers Prev; 24(12); 1902–6. ©2015 AACR.
Viscosity-compensated shear speed imaging with acoustic radiation force
Yang, Yiqun , McGough, Robert J., Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | October 14, 2015 | Volume: 138 | Issue: 3_Supplement | Pages: 1907-1907

10.1121/1.4933996 Get It

Shear wave elastography imaging (SWEI) with ultrasound uses an applied acoustic radiation force to obtain quantitative images of liver, breast, prostate, and other soft tissues. In SWEI, shear velocity waveforms are collected along a line, and then, the shear speed is estimated either with a k-space or a correlation-based method. Although these yield effective estimates in elastic media, both methods consistently overestimate the shear speed in viscoelastic soft tissue because neither considers the shear viscosity. To address this problem, we have created a new shear speed estimation approach that also accounts for the effect of shear viscosity. The new approach is evaluated in a computational model that calculates the three-dimensional (3D) intensity field generated by a linear array transducer in FOCUS (http://www.egr.msu.edu/~fultras-web) and then simulates the shear wave velocities in a viscoelastic medium with a 3D finite difference model. In the viscoelastic shear wave simulation model, the shear speed constant is 1.5 m/s, and the shear viscosity is 1 Pa·s. Correlation-based shear speed estimates are compared to the viscosity-compensated estimates, and the results show that the viscosity-compensated approach consistently achieves improved shear speed estimates relative to the correlation-based method. [Work supported in part by NIH Grant Nos. R01EB012079 and R01DK092255.]
Improving Spiritual Well-Being in Patients with Lung Cancers
Piderman, Katherine M. , Sytsma, Terin T. , Frost, Marlene H., Novotny, Paul J. , Osian, Sarah M. Rausch, Sloan, Jeff A. , Rummans, Teresa A. , Bronars, Carrie, Clark, Matthew M. , Patten, Christi A. , Bronars, Carrie A, Nes, Lise Solberg , Yang, Ping

Mayo Clinic

Journal of Pastoral Care & Counseling: Advancing theory and professional practice through scholarly and reflective publicati | October 13, 2015 | Volume: 69 | Issue: 3 | Pages: 156-162

10.1177/1542305015602711 | PMID 26463853 Get It

Patients with lung cancer report more disease burden and lower spiritual well-being (SWB) compared with other cancer patients. Understanding variables that lessen disease burden and improve SWB is essential. The aim of this study was to explore the relationship between motivational level for physical activity and SWB in patients with lung cancer. Linear regression showed increased SWB as stage of change for physical activity increased (p < 0.0001), even after adjusting for multiple demographic variables.
HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer
Roy, Debarshi , Camacho-Pereira, Juliana , Khurana, Ashwani, Chini, Eduardo N. , Yang, Lifeng , Baddour, Joelle, Stilles, Katherine, Padmabandu, Seth, Leung, Sam, Lowe, Val J. , Dierks, Thomas , Hammond, Edward , Dredge, Keith , Nagrath, Deepak , Shridhar, Viji , Mondal, Susmita, Chini, Eduardo, Mondal, Susmita , Kalloger, Steve E. , Gilks, C. Blake

Mayo Clinic

Oncotarget | September 29, 2015 | Volume: 6 | Issue: 32 | Pages: 33705-33719

10.18632/oncotarget.5605 | PMID 26378042 Get It

Perirenal Fat Promotes Renal Arterial Endothelial Dysfunction in Obese Swine through Tumor Necrosis Factor-α
Ma, Shuangtao , Zhu, Xiang-Yang, Eirin, Alfonso , Woollard, John R. , Jordan, Kyra L., Lerman, Lilach O. , Tang, Hui Jun , Lerman, Amir , Eirin, Alfonso

Mayo Clinic

Journal of Urology | September 29, 2015 | Volume: 195 | Issue: 4 Part 1 | Pages: 1152-1159

10.1016/j.juro.2015.08.105 | PMID 26417644 Get It